NanoSphere Health Sciences and Vertical Companies™ Form Strategic Partnership to Launch Evolve Products in Arizona & California
Cannabis Breakthrough: Precise Cannabinoid Delivery
Licensing agreement will bring the patented NanoSphere Delivery System™ to the world’s largest legal market this summer
DENVER (May 2, 2018)– NanoSphere Health Sciences INC (CSE: NSHS) (OTC: NSHSF), parent company of cannabis brand Evolve Formulas, has joined forces with Vertical™, the largest fully integrated company in the legal medical cannabis industry, to launch Evolve’s growing product line in Arizona and California this summer.
NanoSphere's Evolve Formulas Releases CBD Version of Game-Changing NanoSerum™
Any marketing guru will tell you that the most successful products are those that precisely meet the user’s needs while making as little fuss as possible. This has been a major issue in the cannabis market since day one because drug delivery methods were developed during an era of prohibition, forcing users to set fire to plants and inhale them in dark corners; hardly
Are Transdermals the Future of Cannabis?
New product formula utilizes CBD, THC and resveratrol for rapid repair and rejuvenation with nanotechnology for the ultimate therapy
DENVER, April 30, 2018 /PRNewswire/ -- NanoSphere Health Sciences INC (CSE: NSHS) (OTC: NSHSF), parent company of cannabis brand Evolve Formulas, today announced the latest addition to its cannabis product line-up using NanoSphere Health's patented delivery technology. The new Transdermal NanoSerum™ CBD pen is now available with a desirable 10:1 ratio of CBD:THC. The product will be in Colorado dispensaries starting in mid-May.
Letter from Our Chairman
Dr. Richard Kaufman makes some thoughtful arguments about the speed of transdermal delivery.
NanoSphere Health Sciences Awarded Breakthrough Patent for Disruptive Nanoparticle Delivery Platform
Dear Valued Shareholders,
I would like to take this opportunity to outline the details of a significant milestone for NanoSphere Health Sciences and how this will impact the future of the company. We have been granted our landmark patent for the NanoSphere Delivery System™, which means we now officially have ownership of the biggest advancement in non-invasive medical delivery in over 25 years. A major thank you is in order to everyone who has come on this journey with us, especially those who have been here since the very beginning—from the challenging years of R&D through the pivotal point of commercialization to now, as we realize this new reality and lay the foundation for the bright future of this business.
Nano-Technology Brings Precision to Cannabis
Landmark patent marks most significant advancement in over 25 years for non-invasive medical delivery system
Denver (March 27, 2018) – NanoSphere Health Sciences Inc (CSE: NSHS) (OTC: NSHSF) is pleased to announce that its flagship subsidiary, NanoSphere Health Sciences, LLC, has been granted Patent No. 9,925.149—which covers the core technology behind the production of the NanoSphere Delivery System™—by the United States Patent and Trademark Office.
CFN Media Exclusive Interview with NanoSphere Health Sciences President and COO Mr. David Sutton
CannabisTech had the opportunity to speak with David Sutton, the President and Chief Operating Officer of NanoSphere Health Sciences about their new product Evolve Nanoserum and the technology which made it possible.
President & COO David Sutton interview with Marijuana Times
CFN sat down with NanoSphere Health Sciences COO David Sutton at the recent Seed to Sale show in Denver Colorado.
As research into cannabis has grown, the demand for new and innovative delivery methods has exploded. NanoSphere Health Sciences (NSHS.CN) (CSE:NSHS) (CNSX: NSHS) is disrupting the space through its innovative delivery systems,
NanoSphere Health Sciences’ Cannabis Brand Now Available in Over 100 Dispensaries in Colorado
Tune in to @MarijuanatimesX latest #podcast episode to hear President & COO @davidrsutton discuss the benefits of our delivery system
03-08-2018 Video News – The Marijuana Times Show
Joe Klare discusses final regulations for recreational marijuana in Massachusetts, a case in Texas involving a father giving his autistic daughter medical cannabis and an interview with David Sutton from NanoSphere Health Sciences.
WATCH THE FULL PODCAST HERE
NanoSphere pioneering innovative cannabinoid delivery technology
Evolve Formulas’ Transdermal NanoSerum™ Continues to Expand
DENVER (March 7, 2018) – NanoSphere Health Sciences Inc. (CSE: NSHS/ OTC: NSHSF) cannabis product brand Evolve Formulas is now stocked in over 100 dispensaries throughout Colorado. The company’s pioneering product, Transdermal NanoSerum™, uses the NanoSphere Delivery System™ developed by the biotechnology firm to allow cannabis to enter systemic circulation within ten minutes for fast-acting, effective relief from pain, inflammation and anxiety. This milestone comes on the back of continuous growth, with the company recently signing a licensing agreement in California.
Taking Cannabinoid Absorbency to the Max
DR. LUC DUCHESNE
NanoSphere Health Sciences Inc. (CSE: NSHS) has developed an innovative delivery technology that increases up to six-fold the bioavailability of cannabinoids, marking a significant step forward in the medical cannabis sector.
NanoSphere Health Offers Six-Fold Improvement in Cannabinoid Bioavailability
NanoSphere’s novel retail products and technology present maximum absorbency of cannabinoids for consumers.
NanoSphere Health Sciences Inc. Increases Capacity at Key Colorado Production Facility
The U.S. cannabis industry is projected to exceed $50 billion in size over the coming years, according to Cowen & Co., driven by the legalization of adult-use cannabis in California and other states. While there are many opportunities for investors in the space, since they generate high-margin licensing revenue and don’t touch the plant, biotech firms developing innovative delivery mechanisms offer investors a compelling opportunity.
NanoSphere Health Sciences Presentation Now Available for On-Demand Viewing
Demand for the Company's Groundbreaking Transdermal Evolve NanoSerum™ Driving Production
NanoSphere Health Sciences Inc. Is Nominated For NCIA's Excellence In Technology Award And Recieves OTC Trading Symbol
NanoSphere Health Sciences Inc., based in Denver, focused on nutraceuticals & supplements, cannabis, pharmaceuticals, OTCs, cosmetics, and animal health products, today announced that the January 18 presentation from Victor Goncalves, Executive Vice President, and Dr. Richard Kaufman, Chief Science Officer, is now available for on-demand viewing at VirtualInvestorConferences.com.
NanoSphere Health Sciences Inc. (Formerly Corazon Gold Corp.) Announces Name Change, CSE Listing And Conversion Of $5.9m In Subscription Receipts
NanoSphere Health Sciences Inc. (CSE: NSHS, "NanoSphere") is pleased to announce that it has been nominated for the National Cannabis Industry Association's Excellence in Technology Award in Infused Products and Extraction.
Corazon and NanoSphere Announce Completion of $5.9 Million Financing and Merger
NanoSphere Health Sciences Inc. (CSE: NSHS) ("NanoSphere") (formerly Corazon Gold Corp.) is pleased to announce a name change and listing on the Canadian Securities Exchange (the "CSE"), effective today. NanoSphere's shares will commence trading tomorrow, December 5, 2017, under the symbol "NSHS".
Can Cannabis Replace Benzodiazepines For Anxiety Disorders?
Corazon Gold Corp. (the “Company”) and NanoSphere Health Sciences, LLC (“NanoSphere”) are pleased to announce the closing of the Company’s private placement (the “Offering”) for gross proceeds of $5,905,685, and the completion of the Company’s acquisition (the “Acquisition”) of NanoSphere.
Why Testing? Research Benefits Cannabis Consumers
According to the Anxiety and Depression Association of America, approximately 18 percent of Americans suffer from some form of anxiety disorder.
The commercial sale of marijuana products began in 2014, following the historic vote in Colorado and Washington in November of 2012. The economic impact has been significant and wide-spread throughout the two states ever since. Now in 2017, we are up to eight states that have legalized marijuana for recitational use, and 20 others where marijuana is legalized for medical use.